US Patent Issued to Amgen on April 14 for "Inhibition of SIRP-gamma for cancer treatment" (California Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,650, issued on April 14, was assigned to Amgen Inc. (Thousand Oaks, Calif.).

"Inhibition of SIRP-gamma for cancer treatment" was invented by Ruozhen Hu (Thousand Oaks, Calif.), Paolo Manzanillo (Thousand Oaks, Calif.) and Wenjun Ouyang (Thousand Oaks, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods of treating a subject with a tumor or cancer. In exemplary embodiments, the method comprises increasing an immune response against the tumor or cancer in the subject or increasing effector activity or reducing suppressive activity of T-cells in the subject. In exemplary embodiments, the method comprises administering to ...